Zevra Therapeutics, Inc. (ZVRA)
9.03
-0.14
(-1.53%)
USD |
NASDAQ |
Jan 15, 15:38
Zevra Therapeutics SG&A Expense (TTM): 73.39M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| XOMA Royalty Corp. | 32.68M |
| Verastem, Inc. | 67.48M |
| ADMA Biologics, Inc. | 96.37M |
| Akebia Therapeutics, Inc. | 112.54M |
| NovaBay Pharmaceuticals, Inc. | 8.584M |